Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic-Phase × Valacyclovir × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 3 Waldenstrom Macroglobulinemia 1 Stomatitis 1 Lung Neoplasms 1 Leukemia 1 Head and Neck Neoplasms 1 Glioblastoma 1 Epstein-Barr Virus Infections 1 Cytomegalovirus Infections 1 Brain Neoplasms 1 Adenocarcinoma 1

Interventions

asciminib 8 Dasatinib 7 nilotinib 6 Imatinib Mesylate 5 bosutinib 4 Cyclophosphamide 4 ponatinib 3 fludarabine phosphate 3 Whole-Body Irradiation 3 ruxolitinib 2 letermovir 2 Tacrolimus 2 Specimen Handling 2 Peripheral Blood Stem Cell Transplantation 2 Mycophenolic Acid 2 Methotrexate 2 Melphalan 2 Cyclosporine 2 Busulfan 2 venetoclax 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 olverembatinib 1 decitabine and cedazuridine drug combination 1 Vorinostat 1 Valganciclovir 1 Tyrosine Kinase Inhibitors 1 Therapeutics 1 Stem Cell Transplantation 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡